Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 1286198, 6 pages
https://doi.org/10.1155/2017/1286198
Research Article

Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers

1Department of Gastroenterology, Oita University Faculty of Medicine, Oita, Japan
2Takada Chuo Hospital, Oita, Japan
3The Bungotakada City Medical Association, Oita, Japan
4Oita Kouseiren Tsurumi Hospital, Oita, Japan
5Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Oita, Japan

Correspondence should be addressed to Kazuhiro Mizukami; pj.ca.u-atio@9080zakzim

Received 3 March 2017; Revised 24 April 2017; Accepted 14 May 2017; Published 11 June 2017

Academic Editor: Tatsuya Toyokawa

Copyright © 2017 Mitsutaka Shuto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. IARC Helicobacter pylori Working group, “Helicobacter pylori eradication as a strategy for preventing gastric cancer,” International Agency for Research on Cancer (IARC Working Group Reports, No. 8), Lyon, France, 2014. View at Google Scholar
  2. N. Uemura, S. Okamoto, S. Yamamoto et al., “Helicobacter pylori infection and the development of gastric cancer,” The New England Journal of Medicine, vol. 345, pp. 784–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Asaka, M. Kato, S. Takahashi et al., “Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition,” Helicobacter, vol. 15, pp. 1–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Watabe, T. Mitsushima, Y. Yamaji et al., “Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study,” Gut, vol. 54, pp. 764–768, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Miki, “Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-“ABC method”,” Proceeding of the Japan Academy, Series B, vol. 87, no. 7, pp. 405–414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Mizuno, I. Miki, T. Ishida et al., “Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis,” Digestive Diseases and Sciences, vol. 55, pp. 3132–3137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Nomura, G. N. Stemmermann, P.-H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser, “Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii,” The New England Journal of Medicine, vol. 325, pp. 1132–1136, 1991. View at Publisher · View at Google Scholar
  8. Y. Watanabe, J. H. Kurata, S. Mizuno et al., “Helicobacter pylori infection and gastric cancer: a nested case-control study in a rural area of Japan,” Digestive Diseases and Sciences, vol. 42, pp. 1383–1387, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Burucoa, J. C. Delchier, A. Courillon-Mallet et al., “Comparative evaluation of 29 commercial Helicobacter pylori serological kits,” Helicobacter, vol. 18, pp. 169–179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Malfertheiner, F. Megraud, C. O’Morain et al., “Current concepts in the management of Helicobacter pylori infection: the Maastricht-3 consensus report,” Gut, vol. 56, pp. 772–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. F. Cutler and V. M. Prasad, “Long-term follow-up of Helicobacter pylori serology after successful eradication,” The American Journal of Gastroenterology, vol. 91, pp. 85–88, 1996. View at Google Scholar
  12. T. Boda, M. Ito, M. Yoshihara et al., “Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm,” Helicobacter, vol. 19, no. 1, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. B. A. Salih, M. F. Abasiyanik, H. Saribasak, O. Huten, and E. Sander, “A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology,” Digestive Diseases and Sciences, vol. 50, pp. 1517–1522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Koizumi, S. Tanabe, H. Imaizumi et al., “Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection,” Hepato-Gastroenterology, vol. 50, pp. 293–296, 2003. View at Google Scholar
  15. W. D. Chey and B. C. Wong, “American college of gastroenterology guideline on the management of Helicobacter pylori infection,” The American Journal of Gastroenterology, vol. 102, pp. 1808–1825, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Fock, N. Talley, P. Moayyedi et al., “Asia-Pacific consensus guidelines on gastric cancer prevention,” Journal of Gastroenterology and Hepatology, vol. 23, pp. 351–365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Hamashima, D. Shibuya, H. Yamazaki et al., “The Japanese guidelines for gastric cancer screening,” Japanese Journal of Clinical Oncology, vol. 38, pp. 259–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Malfertheiner, F. Megraud, C. O’Morain et al., “Management of Helicobacter pylori infection: the Maastricht-5 consensus report,” Gut, vol. 66, pp. 6–30, 2017. View at Google Scholar
  19. T. Matsuo, M. Ito, S. Takata, S. Tanaka, M. Yoshihara, and K. Chayama, “Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese,” Helicobacter, vol. 16, pp. 415–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kishikawa, K. Kimura, A. Ito et al., “Predictors of gastric neoplasia in cases negative for Helicobacter pylori antibody and with normal pepsinogen,” Anticancer Research, vol. 35, pp. 6765–6772, 2015. View at Google Scholar
  21. M. Tatemichi, S. Sasazuki, M. Inoue, and S. Tsugane, “Clinical significance of IgG antibody titer against Helicobacter pylori,” Helicobacter, vol. 14, pp. 231–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Suzuki, H. Cullings, S. Fujiwara et al., “Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene a (CagA) may predict future gastric cancer better than simple seropositivity against H. Pylori CagA or against H. Pylori,” Cancer Epidemiology, Biomarkers & Prevention, vol. 16, pp. 1224–1228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Yamaji, T. Mitsushima, H. Ikuma et al., “Weak response of Helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10,234 endoscoped Japanese,” Scandinavian Journal of Gastroenterology, vol. 37, pp. 148–153, 2002. View at Google Scholar
  24. H. Kishikawa, J. Nishida, H. Ichikawa et al., “Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status,” Helicobacter, vol. 16, pp. 427–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. The Japanese Society for Helicobacter Research (JSHR), “Attention awakening from the Japanese Society for Helicobacter Research (JSHR) about positive, the negative judgment of the examination of serum H. pylori IgG antibody (in Japanese),” http://www.jshr.jp/pdf/info/topics/20150630_igg.pdf.
  26. K. Kimura and T. Takemoto, “An endoscopic recognition of the atrophic border and its significance in chronic gastritis,” Endoscopy, vol. 1, no. 3, pp. 87–97, 1969. View at Google Scholar
  27. T. Itoh, M. Saito, N. Marugami et al., “Correlation between the ABC classification and radiological findings for assessing gastric cancer risk,” Japanese Journal of Radiology, vol. 33, pp. 636–644, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Gotoda, H. Ishikawa, H. Ohnishi et al., “Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy,” Gastric Cancer, vol. 18, pp. 605–611, 2015. View at Publisher · View at Google Scholar · View at Scopus